Reig Jofre takes over Leanbio

Biopharma company Reig Jofre (BME: RJF) has consolidated its stake in Leanbio, a fellow Barcelona-based firm focused on the design, development, characterization and production of biotechnology-based active pharmaceutical ingredients.

Reig Jofre’s shareholding in Leanbio has thus increased from the previous 47% to the current 85%, following the acquisition of equity interests from existing shareholders for a total consideration of 3.5 million euros ($4.1 million). The remaining 15% of the share capital remains in the hands of the founding team and specialized investors.